Testing effectiveness (Phase 2)Ended earlyNCT05123040
What this trial is testing
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
Who this might be right for
Acute-graft-versus-host Disease
Masonic Cancer Center, University of Minnesota 10